Who owns ACTINIUM PHARMACEUTICALS INC?
- Ticker: ATNM
- CUSIP Number: 00507w206
Tip: Access positions for across all investors
Analyze quarterly positions in Actinium Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Actinium Pharmaceuticals stock
Who bought or sold ACTINIUM PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.4M | $6.9M | 2% | Dec 2023 |
|
| Dimensional Fund Advisors | 147k | $749k | -9% | Dec 2023 |
|
| Brandywine Global Investment Management | 146k | $740k | -17% | Dec 2023 |
|
| Citadel Advisors | 87k | $440k | -43% | Dec 2023 |
|
| Charles Schwab Investment Management | 76k | $387k | 0% | Dec 2023 |
|
| Bank of New York Mellon | 67k | $528k | -41% | Mar 2024 |
|
| Royce & Associates | 50k | $254k | 0% | Dec 2023 |
|
| Bank of America Corporation | 50k | $252k | 19% | Dec 2023 |
|
| Barclays | 38k | $192k | 711% | Dec 2023 |
|
| Rhumbline Advisers | 32k | $161k | 3% | Dec 2023 |
|
| UBS Group | 30k | $151k | 145% | Dec 2023 |
|
| Jane Street | 30k | $151k | 100% | Dec 2023 |
|
| Creative Financial Designs | 23k | $179k | 15% | Mar 2024 |
|
| Virtu Financial | 20k | $99k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 19k | $94k | 2% | Dec 2023 |
|
| Goldman Sachs Group | 16k | $79k | -67% | Dec 2023 |
|
| National Asset Management | 15k | $74k | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 14k | $72k | -7% | Dec 2023 |
|
| MetLife Investment Advisors | 14k | $70k | 0% | Dec 2023 |
|
| American International | 14k | $69k | 2% | Dec 2023 |
|
| Royal Bank of Canada | 14k | $71k | 60% | Dec 2023 |
|
| New York State Common Retirement Fund | 13k | $64k | 0% | Dec 2023 |
|
| Am Investment Strategies | 13k | $99k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 12k | $63k | 16% | Dec 2023 |
|
| Perritt Capital Management | 12k | $61k | 0% | Dec 2023 |
|
| Sanders Morris Harris | 10k | $78k | 100% | Mar 2024 |
|
| Simplex Trading | 9.1k | $71k | -47% | Mar 2024 |
|
| Advisor Group Holdings | 6.7k | $34k | -9% | Dec 2023 |
|
| Citigroup | 3.9k | $20k | 19530% | Dec 2023 |
|
| Legal & General Group | 3.0k | $15k | 17% | Dec 2023 |
|
| Summit Investment Advisors | 2.1k | $11k | 0% | Dec 2023 |
|
| Advisory Services Network | 2.1k | $11k | 100% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 1.4k | $7.3k | 0% | Dec 2023 |
|
| Retirement Group | 1.2k | $9.3k | 0% | Mar 2024 |
|
| Amalgamated Bank | 877.00 | $7.0k | -76% | Mar 2024 |
|
| National Bank Of Canada /fi/ | 855.00 | $4.5k | 0% | Dec 2023 |
|
| BFSG | 500.00 | $3.9k | 0% | Mar 2024 |
|
| Hartford Financial Management | 266.00 | $2.1k | 0% | Mar 2024 |
|
| Steward Partners Investment Advisory | 100.00 | $508.000000 | 0% | Dec 2023 |
|
| CWM | 91.00 | $999.999000 | -49% | Mar 2024 |
|
| Coppell Advisory Solutions | 7.00 | $36.000300 | 100% | Dec 2023 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 5.00 | $39.000000 | 100% | Mar 2024 |
|
Who sold out of Actinium Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| D. E. Shaw & Co | Sep 2023 | 18k | $107k |
| Mirae Asset Global Investments | Dec 2023 | 14k | $73k |
| J. Goldman & Co | Sep 2023 | 14k | $80k |
| Hazlett, Burt & Watson | Dec 2023 | 200.00 | $1.0k |
| Gradient Investments | Dec 2023 | 66.00 | $335.002800 |
| Russell Investments | Sep 2023 | 39.00 | $231.000900 |
| Signature | Sep 2023 | 8.00 | $47.000000 |